MedTrace Logo

Pharmacokinetics of Intravenous Metamizole in Children Less Than 6 Years Old

NCT02660177 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-05-30

No results posted yet for this study

Summary

This study aims to assess the PK parameters of metamizole following a single IV administration of metamizole in children less than 6 years of age.

Conditions

  • Children
  • Pain
  • Surgery

Interventions

DRUG

Metamizole

metamizole IV administration

Sponsors & Collaborators

  • University Children's Hospital Basel

    lead OTHER

Principal Investigators

  • Marc Pfister, Professor · University Children's Hospital Basel

  • Rodieux Frederique, Dr. med · University Hospital, Geneva

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Months
Max Age
72 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660177 on ClinicalTrials.gov